Put Down the Pom-Poms. You Weren't a Fan Last Year.

I have been teaching peptide therapy for years. Years. When most of the people currently selling you courses, stacks, and transformation stories were still posting gym selfies and pyramid scheme skincare, I was in rooms full of physicians, naturopaths, nurses, and pharmacists - learning, teaching, debating, refining protocols, and caring deeply about getting this right.

And now I open social media, and I cannot scroll for six seconds before I hit another overnight expert with a ring light, a Canva template, and a peptide stack they are absolutely certain will change your life.

Let me be very direct with you: I am not mad. I am concerned. Because peptides are extraordinary. The science is real, the clinical applications are significant, and the potential to change lives is genuine. And none of that is served by people who discovered this field last Tuesday and are now charging you $497 for a masterclass.

Knowing the brand name of a peptide is not the same as knowing the peptide. And definitely not the same as knowing the patient.

The bandwagon problem - a brief history

You know this person. You have met this person. Every few years, they show up with the next thing. The MLM years were particularly instructive. A friend of a friend joins a wellness company. Within six weeks, they are a Diamond Executive Leader who has discovered the secret to everything and would love to share it with you over coffee - which will definitely not turn into a two-hour recruitment pitch delivered at low-grade intensity until you buy a starter kit to make them stop.

You stopped picking up the phone. Your whole friend group did. Because when someone leads with “I’m just so passionate about helping people” and follows it with a QR code and a team-building dinner, you learn to recognize the pattern. The passion was real. The expertise was not.

The sports version is equally recognizable. The team wins a championship and suddenly half the people you know have been die-hard fans their whole life. They own a jersey. They have opinions about the offensive line. They cannot name a single player from two seasons ago. The bandwagon is comfortable because there are a lot of people on it, and nobody checks credentials at the door.

The current peptide bandwagon, explained

Here is the 2024–2025 playbook: discover peptides (usually via a podcast, a biohacker, or someone who discovered them the month before). Purchase a product labeled “not for human use” - the research chemical classification that exists precisely because these compounds have not gone through the clinical governance required to be prescribed to humans. Begin using it personally. Report results on social media. Attract followers who want the same results. Launch an educational platform. Sign affiliate deals. Repeat.

At no point in this sequence does anyone ask: what is this compound actually doing at the receptor level? What are the contraindications? What is the half-life? What does the monitoring protocol look like? Who is the patient who should not have this?

Those questions are the difference between a clinical tool and a trend. The trend is fun until someone gets hurt.

Spot the “expert” - a field guide

Social media peptide expert bingo

1. Discovered peptides 6–18 months ago. Has already written a book, launched a course, and keynoted a summit.

2. Sources exclusively from “research grade” suppliers. Says “not for human use” is just a legal technicality. It is not.

3. Has affiliate codes for at least 4 peptide companies. The recommendations and the revenue are directly connected. Always.

4. Cannot explain the mechanism of action without reading from a script. Can explain the price of their course without hesitation.

5. Lists “biohacker,” “longevity enthusiast,” or “health optimizer” as credentials. These are interests, not training.

6. The HCP who took a weekend course and is now the peptide authority in their network. One certification does not a specialist make.

7. Claims their “stack” is revolutionary. It is BPC-157, TB-500, and a GLP-1. The internet has been talking about all three for years.

8. Has never adjusted a protocol based on a patient lab result because there are no patients. There is only content.

The “not for human use” conversation we need to have

Let me be precise here because this matters. Research chemicals labeled “not for human use” carry that designation for a regulatory reason - they have not been through the manufacturing, testing, stability, purity verification, and pharmacovigilance processes required to be administered to a human being under clinical supervision. That label is not bureaucratic overcaution. It is the system working as designed.

When someone buys a “not for human use” compound, reconstitutes it in conditions they have set up themselves, and injects it based on dosing advice from a social media post - they are not biohacking. They are running an uncontrolled human experiment with an unverified compound on themselves, guided by someone with no clinical accountability for what happens next.

The irony is that the same compounds, sourced from a pharmaceutical-grade laboratory, prescribed by a qualified clinician, dosed according to a monitored protocol - are genuinely remarkable. I have seen what they do for real patients, in real clinical settings, over real time periods. That is why I have dedicated years of my career to teaching this properly. The tool is extraordinary. The governance around it is what makes it safe enough to be worth anything.

The bandwagon version

• Source: Research chemical supplier. “Not for human use.”

• Dosing: Reddit thread + influencer recommendation.

• Monitoring: How do you feel? Good? Great.

• Education: Weekend course. Or a podcast. Or just vibes.

• Accountability: Their disclaimer says “consult a doctor.” You didn’t.

• When it goes wrong: The content creator is already on to the next thing.

The clinical version

• Source: Pharmaceutical-grade laboratory. Documented purity and viability.

• Dosing: Based on baseline labs, patient history, and clinical protocol.

• Monitoring: Interval labs, symptom tracking, protocol adjustment.

• Education: 150-hour certification. Clinical faculty. Evidence-based curriculum.

• Accountability: A licensed clinician whose name is on the prescription.

• When it goes wrong: There is a clinical pathway to identify and address it.

Why I am still here - and still this passionate

I want to be very clear about something: my frustration with the bandwagon is not protectionism. I am not angry that more people are talking about peptides. I am frustrated that the conversation happening at scale does not reflect the science, does not serve the patients, and will eventually produce the kind of regulatory backlash that makes this entire field harder to practice responsibly.

Peptides are one of the most versatile, evidence-supported tools in regenerative medicine. The research on BPC-157 for tissue repair, on GHRPs for growth hormone optimization, on Semax and Selank for neuroprotection, on Epithalon for cellular aging - it is serious science, published in peer-reviewed journals, with clinical applications that are changing patient outcomes. That deserves serious practitioners. It deserves governance. It deserves the kind of clinical education that takes more than a weekend to complete.

We have hundreds of peptide protocols based on patient outcomes over the past decade and from experienced medical doctors, all over the world. We educate and certify in 20 countries and growing. I have personally seen what these compounds can do for the patient who is appropriately selected, properly dosed, and correctly monitored - and I have seen what happens when the selection, dosing, and monitoring are absent. They are not the same story.

I didn’t build 24 years of expertise so you could get the same information from someone who read three PubMed abstracts and started a Substack.

Don’t follow the bandwagon. Follow the evidence.

If you are a clinician who wants to practice peptide therapy at the standard it deserves, with real clinical training, pharmaceutical-grade sourcing, and governance frameworks that protect your patients and your license, MedBridge Global exists for exactly that reason.

If you are a patient trying to understand whether what someone on social media is telling you is real, bring that question to a qualified clinician who has done the work. Ask them where they trained. Ask them where their compounds come from. Ask them what happens if something goes wrong. The answers will tell you everything.

The bandwagon will move on to the next thing. The science will still be here. So will I.

Learn at MedBridge Global →